October 21, 2015 FDA staff reviewers question safety of AstraZeneca's gout drug Staff reviewers of the U.S. Food and Drug Administration have raised questions about the safety of AstraZeneca Plc's gout treatment.
October 20, 2015 Johnson & Johnson's Stelara succeeds in Phase III Crohn's disease trial Johnson & Johnson's Stelara was significantly better than placebo at inducing clinical response and remissions in patients with moderate to severe Crohn's disease, according to data from a late stage trial, providing ammunition for a potential expanded approval of the medicine.
October 19, 2015 New genital herpes treatment shows promise A new drug appears to combat the virus that causes genital herpes, suggesting it could one day be used as a treatment for people with the condition, according to a new study
September 29, 2015 Drug prices should benefit patients, not industry When hedge fund trader Martin Shkreli purchased a pharmaceutical company and raised the price of an HIV medication that treats potentially fatal infections from $13.50 to $750 per pill, he threatened the well-being of all Americans.
July 23, 2015 6 crucial questions to ask before filling a prescription “Do you have any questions?” You’ll hear it from your doctor, the nurse and likely the pharmacist when you get a new prescription.
June 18, 2015 Few US stroke patients get clot-busting treatment Not all U.S. stroke patients eligible for a clot-busting treatment actually receive it - and the odds of getting this therapy may depend on where they live, a large study finds.
June 12, 2015 Find out if your doctor takes payments from drug companies When you walk into your doctor’s office and see clipboards and pens emblazoned with brand names of drugs, do you ever wonder just how much money he or she is getting from pharmaceutical companies...
June 12, 2015 New advice for vaccines to stave off pneumonia People age 65 and older should get two separate vaccines to protect against pneumonia and other infections starting this fall, a change of decades-old advice, according to new health guidelines.
February 5, 2015 FDA lowers starting dose of sleep drug Lunesta over safety U.S. health regulators on Thursday said they required a label change for the sleep drug Lunesta to cut the recommended starting dose over concerns it could impair alertness in some people the following morning.
February 5, 2015 Bristol-Myers hepatitis C treatment cures up to 90 percent in new study A combination of two anti-viral drugs developed by Bristol-Myers Squibb Co cured 90 percent of previously untreated hepatitis C patients and 82 percent of those who failed to respond to prior therapy, according to results from a late stage study presented on Thursday.
